Diagnos, Inc. (ADK.V)
0.37
-0.02
(-3.90%)
CAD |
TSXV |
Oct 23, 16:00
Diagnos Net Income (Quarterly) : -1.184M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.184M |
| December 31, 2025 | -1.161M |
| September 30, 2025 | -1.096M |
| June 30, 2025 | -1.113M |
| March 31, 2025 | -1.337M |
| December 31, 2024 | -1.213M |
| September 30, 2024 | -1.019M |
| June 30, 2024 | -0.7167M |
| March 31, 2024 | -0.8088M |
| December 31, 2023 | -0.81M |
| September 30, 2023 | -0.7496M |
| June 30, 2023 | -0.7522M |
| March 31, 2023 | -0.729M |
| December 31, 2022 | -0.514M |
| September 30, 2022 | -0.5207M |
| June 30, 2022 | -0.7172M |
| March 31, 2022 | -0.7254M |
| December 31, 2021 | -0.6051M |
| September 30, 2021 | -0.5577M |
| June 30, 2021 | -0.72M |
| March 31, 2021 | -0.63M |
| December 31, 2020 | -0.5728M |
| September 30, 2020 | -0.3522M |
| June 30, 2020 | -0.4963M |
| March 31, 2020 | -1.264M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.5675M |
| September 30, 2019 | -0.5465M |
| June 30, 2019 | -1.005M |
| March 31, 2019 | -0.7475M |
| December 31, 2018 | -1.034M |
| September 30, 2018 | -1.101M |
| June 30, 2018 | -0.9572M |
| March 31, 2018 | -1.042M |
| December 31, 2017 | -0.5444M |
| September 30, 2017 | -0.8346M |
| June 30, 2017 | -1.348M |
| March 31, 2017 | -1.292M |
| December 31, 2016 | 0.0623M |
| September 30, 2016 | -1.110M |
| June 30, 2016 | -0.603M |
| March 31, 2016 | -0.8703M |
| December 31, 2015 | -0.7166M |
| September 30, 2015 | -0.9882M |
| June 30, 2015 | -0.6997M |
| March 31, 2015 | -0.6837M |
| December 31, 2014 | -0.6709M |
| September 30, 2014 | -0.7874M |
| June 30, 2014 | -0.6856M |
| March 31, 2014 | -0.5449M |
| December 31, 2013 | -0.4483M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Evokai Creative Labs, Inc. | -- |
| Arch Biopartners, Inc. | -0.4751M |
| Avricore Health, Inc. | -0.2754M |
| Kane Biotech, Inc. | -0.8336M |
| CardioComm Solutions, Inc. | -0.1967M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0157M |
| Total Expenses (Quarterly) | 1.200M |
| EPS Diluted (Quarterly) | -0.0098 |
| Enterprise Value | 44.03M |
| Gross Profit Margin (Quarterly) | -2.24K% |
| Profit Margin (Quarterly) | -7.54K% |
| Earnings Yield | -11.16% |
| Normalized Earnings Yield | -11.22 |